Free Trial

NICE (NCSYF) Financials

NICE logo
$121.62 +24.20 (+24.84%)
As of 03:48 PM Eastern
Annual Income Statements for NICE

Annual Income Statements for NICE

This table shows NICE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
259 117 143 159 186 196 199 266 338 443 612
Consolidated Net Income / (Loss)
259 117 143 159 186 196 199 266 338 443 612
Net Income / (Loss) Continuing Operations
141 123 143 159 186 196 199 266 338 443 612
Total Pre-Tax Income
171 144 130 187 234 237 241 345 458 605 704
Total Operating Income
166 134 150 198 239 242 264 335 435 546 646
Total Gross Profit
623 678 863 948 1,042 1,086 1,297 1,498 1,609 1,826 1,956
Total Revenue
927 1,016 1,332 1,445 1,574 1,648 1,921 2,181 2,378 2,735 2,945
Operating Revenue
927 1,016 1,332 1,445 1,574 1,648 1,921 2,181 2,378 2,735 2,945
Total Cost of Revenue
304 338 469 497 532 562 624 684 768 910 989
Operating Cost of Revenue
304 338 469 497 532 562 624 684 768 910 989
Total Operating Expenses
457 544 713 750 803 844 1,033 1,162 1,174 1,280 1,310
Selling, General & Admin Expense
90 117 129 153 168 181 225 247 252 277 289
Marketing Expense
226 268 361 413 442 445 536 610 599 642 661
Research & Development Expense
128 142 181 184 194 218 271 306 323 361 360
Total Other Income / (Expense), net
5.30 10 -20 -11 -4.44 -4.86 -23 10 22 59 58
Other Income / (Expense), net
5.30 10 -20 -11 -4.44 -4.86 -23 10 22 59 58
Income Tax Expense
31 21 -14 27 48 41 41 79 119 162 92
Basic Earnings per Share
$4.35 $1.96 $2.37 $2.60 $2.99 $3.13 $3.15 $4.17 $5.32 $6.97 $9.82
Weighted Average Basic Shares Outstanding
59.55M 59.67M 60.44M 61.39M 62.12M 62.71M 63.19M 63.79M 63.59M 63.48M 62.33M
Diluted Earnings per Share
$4.22 $1.92 $2.31 $2.52 $2.88 $2.98 $2.98 $4.00 $5.11 $6.76 $9.67
Weighted Average Diluted Shares Outstanding
61.28M 61.04M 62.12M 63.31M 64.66M 65.96M 66.90M 66.47M 66.27M 65.51M 63.32M
Weighted Average Basic & Diluted Shares Outstanding
59.53M 59.99M 60.93M 61.77M 62.40M 63.05M 63.48M 63.63M 62.87M 63.25M 60.43M

Quarterly Income Statements for NICE

No quarterly income statements for NICE are available.


Annual Cash Flow Statements for NICE

This table details how cash moves in and out of NICE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
138 -169 171 -86 -14 214 -64 154 -20 -28 -103
Net Cash From Operating Activities
252 228 395 397 374 480 462 480 561 833 717
Net Cash From Continuing Operating Activities
252 228 395 397 374 480 462 480 561 833 717
Net Income / (Loss) Continuing Operations
259 117 143 159 186 196 199 266 338 443 612
Consolidated Net Income / (Loss)
259 117 143 159 186 196 199 266 338 443 612
Depreciation Expense
58 78 156 157 173 182 184 177 167 205 199
Amortization Expense
2.80 2.82 14 8.07 9.18 13 26 13 7.10 -8.03 2.68
Non-Cash Adjustments To Reconcile Net Income
-118 46 56 68 98 121 183 205 202 198 155
Changes in Operating Assets and Liabilities, net
51 -16 25 3.81 -92 -32 -131 -181 -154 -5.01 -252
Net Cash From Investing Activities
-28 -800 -213 -461 -344 -465 -261 -152 -294 -397 160
Net Cash From Continuing Investing Activities
-28 -800 -213 -461 -344 -465 -261 -152 -294 -397 160
Purchase of Property, Plant & Equipment
-18 -36 -68 -64 -62 -63 -67 -82 -84 -100 -94
Acquisitions
0.00 -1,156 -76 -105 -26 -147 -143 -30 -415 -65 -856
Purchase of Investments
-289 -49 -133 -430 -619 -583 -322 -396 -230 -938 -93
Sale and/or Maturity of Investments
93 450 64 137 363 329 271 356 436 705 1,203
Net Cash From Financing Activities
-79 405 -15 -16 -43 197 -262 -164 -290 -457 -984
Net Cash From Continuing Financing Activities
-79 405 -15 -16 -43 197 -262 -164 -290 -457 -984
Repayment of Debt
0.00 -1.09 -260 -0.88 0.00 -215 -177 -20 -2.63 -192 -460
Repurchase of Common Equity
-68 -44 -24 -26 -47 -48 -73 -145 -288 -369 -489
Payment of Dividends
-38 -38 -9.64 - 0.00 0.00 -16 -0.38 -1.77 -3.04 -36
Issuance of Common Equity
28 24 19 19 5.43 8.87 4.43 0.95 2.57 3.06 1.11
Other Financing Activities, net
-0.30 0.00 0.00 -8.44 -0.82 -0.18 - 0.00 0.00 105 0.00
Effect of Exchange Rate Changes
-6.11 -2.55 4.42 -5.78 -0.98 1.87 -2.11 -8.43 2.64 -6.91 4.73
Cash Interest Paid
0.11 2.20 7.91 12 11 7.83 0.69 2.97 1.22 0.24 0.22
Cash Income Taxes Paid
54 28 33 43 65 83 97 124 19 19 28

Quarterly Cash Flow Statements for NICE

No quarterly cash flow statements for NICE are available.


Annual Balance Sheets for NICE

This table presents NICE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,850 2,632 2,845 3,207 3,610 4,233 4,710 4,854 5,118 5,296 5,106
Total Current Assets
655 509 693 861 876 1,942 2,298 2,417 2,313 2,505 1,379
Cash & Equivalents
326 157 328 242 228 442 379 530 512 482 379
Short-Term Investments
99 30 64 244 211 1,022 1,046 1,042 896 1,140 38
Accounts Receivable
177 260 231 288 320 303 396 519 585 644 738
Prepaid Expenses
44 62 70 87 117 175 185 205 198 239 224
Plant, Property, & Equipment, net
41 88 118 140 142 138 146 159 174 185 189
Total Noncurrent Assets
1,154 2,035 2,034 2,206 2,593 2,153 2,267 2,278 2,630 2,606 3,538
Goodwill
651 1,285 1,318 1,366 1,378 1,503 1,607 1,617 1,822 1,850 2,441
Intangible Assets
68 619 551 508 411 366 295 210 306 231 588
Noncurrent Deferred & Refundable Income Taxes
14 14 12 12 31 33 55 117 179 219 198
Other Noncurrent Operating Assets
17 19 19 74 230 251 310 334 324 306 311
Total Liabilities & Shareholders' Equity
1,850 2,632 2,845 3,207 3,610 4,233 4,710 4,854 5,118 5,296 5,106
Total Liabilities
434 1,121 1,096 1,191 1,353 1,644 1,872 1,799 1,763 1,693 1,230
Total Current Liabilities
379 473 523 625 941 1,044 1,270 1,141 1,120 1,474 888
Short-Term Debt
0.00 21 0.00 0.00 252 260 396 209 209 459 0.00
Accounts Payable
235 302 339 404 422 450 524 579 595 704 570
Current Deferred Revenue
131 150 185 221 246 312 330 339 303 299 304
Other Current Liabilities
- - - 0.00 22 22 20 14 14 13 14
Total Noncurrent Liabilities
56 648 572 566 412 600 603 658 643 218 342
Noncurrent Deferred Revenue
20 23 38 35 26 36 67 57 52 66 61
Noncurrent Deferred & Payable Income Tax Liabilities
15 147 58 44 53 32 7.43 7.34 8.60 1.97 110
Other Noncurrent Operating Liabilities
18 34 29 31 120 110 100 138 125 150 170
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,415 1,511 1,750 2,017 2,257 2,588 2,838 3,055 3,355 3,603 3,877
Total Preferred & Common Equity
1,415 1,511 1,750 2,017 2,257 2,564 2,825 3,042 3,341 3,590 3,877
Total Common Equity
1,415 1,511 1,750 2,017 2,257 2,564 2,825 3,042 3,341 3,590 3,877
Common Stock
1,252 1,336 1,439 1,519 1,587 1,701 1,837 1,970 2,142 2,298 2,401
Retained Earnings
632 711 851 1,072 1,258 1,454 1,654 1,926 2,263 2,702 3,314
Treasury Stock
-445 -489 -508 -527 -554 -574 -626 -743 -1,005 -1,339 -1,803
Accumulated Other Comprehensive Income / (Loss)
-24 -47 -33 -47 -33 -17 -40 -111 -59 -71 -36
Noncontrolling Interest
- - - - 0.00 25 13 13 13 13 0.00

Quarterly Balance Sheets for NICE

No quarterly balance sheets for NICE are available.


Annual Metrics And Ratios for NICE

This table displays calculated financial ratios and metrics derived from NICE's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.29% 9.57% 31.18% 8.44% 8.96% 4.71% 16.57% 13.54% 9.00% 15.05% 7.68%
EBITDA Growth
25.17% -3.05% 33.34% 17.25% 18.40% 3.65% 4.44% 18.56% 18.21% 26.84% 12.96%
EBIT Growth
55.74% -15.71% -10.26% 44.00% 25.47% 1.24% 1.45% 43.52% 32.54% 32.14% 16.40%
NOPAT Growth
40.84% -16.10% 45.11% 1.68% 12.33% 5.77% 9.05% 18.13% 24.63% 24.19% 40.54%
Net Income Growth
151.11% -54.83% 22.55% 11.20% 16.67% 5.62% 1.47% 33.49% 27.21% 30.83% 38.30%
EPS Growth
149.70% -54.50% 20.31% 9.09% 14.29% 3.47% 0.00% 34.23% 27.75% 32.29% 43.05%
Operating Cash Flow Growth
38.44% -9.56% 72.94% 0.49% -5.66% 28.37% -3.85% 3.88% 17.03% 48.31% -13.94%
Free Cash Flow Firm Growth
33.45% -528.14% 118.73% -46.25% 92.45% -29.03% -258.32% 262.54% -141.01% 500.94% -179.94%
Invested Capital Growth
-13.62% 185.17% -1.09% 4.16% -0.06% 3.74% 23.96% -4.01% 21.62% -6.61% 41.75%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
67.25% 66.74% 64.82% 65.61% 66.21% 65.90% 67.50% 68.66% 67.69% 66.75% 66.41%
EBITDA Margin
25.05% 22.17% 22.53% 24.36% 26.47% 26.21% 23.48% 24.52% 26.59% 29.31% 30.75%
Operating Margin
17.92% 13.21% 11.27% 13.68% 15.17% 14.69% 13.74% 15.37% 18.31% 19.96% 21.92%
EBIT Margin
18.49% 14.23% 9.73% 12.93% 14.88% 14.39% 12.52% 15.83% 19.25% 22.11% 23.90%
Profit (Net Income) Margin
27.93% 11.51% 10.76% 11.03% 11.81% 11.91% 10.37% 12.19% 14.23% 16.18% 20.78%
Tax Burden Percent
151.00% 80.92% 110.51% 85.34% 79.35% 82.78% 82.80% 77.01% 73.91% 73.18% 86.94%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
17.99% 14.82% -10.51% 14.66% 20.65% 17.22% 17.20% 22.99% 26.09% 26.82% 13.06%
Return on Invested Capital (ROIC)
21.30% 10.01% 9.86% 9.88% 10.88% 11.30% 10.81% 11.77% 13.51% 15.81% 19.03%
ROIC Less NNEP Spread (ROIC-NNEP)
3.13% 9.19% -34.49% 15.16% 11.77% 11.92% 13.60% 10.73% 11.50% 11.29% 12.62%
Return on Net Nonoperating Assets (RNNOA)
-1.61% -2.02% -1.08% -1.42% -2.18% -3.20% -3.46% -2.74% -2.96% -3.09% -2.67%
Return on Equity (ROE)
19.69% 7.99% 8.79% 8.46% 8.70% 8.10% 7.34% 9.03% 10.56% 12.72% 16.37%
Cash Return on Invested Capital (CROIC)
35.92% -86.14% 10.96% 5.80% 10.94% 7.63% -10.59% 15.86% -5.99% 22.65% -15.51%
Operating Return on Assets (OROA)
9.84% 6.45% 4.73% 6.17% 6.87% 6.05% 5.38% 7.22% 9.18% 11.62% 13.54%
Return on Assets (ROA)
14.86% 5.22% 5.23% 5.27% 5.45% 5.01% 4.46% 5.56% 6.79% 8.50% 11.77%
Return on Common Equity (ROCE)
19.69% 7.99% 8.79% 8.46% 8.70% 8.06% 7.29% 8.99% 10.51% 12.67% 16.34%
Return on Equity Simple (ROE_SIMPLE)
18.29% 7.74% 8.19% 7.90% 8.24% 7.66% 7.05% 8.74% 10.13% 12.33% 0.00%
Net Operating Profit after Tax (NOPAT)
136 114 166 169 189 200 219 258 322 400 561
NOPAT Margin
14.70% 11.25% 12.45% 11.67% 12.04% 12.16% 11.37% 11.83% 13.53% 14.61% 19.06%
Net Nonoperating Expense Percent (NNEP)
18.17% 0.82% 44.36% -5.28% -0.89% -0.62% -2.79% 1.04% 2.02% 4.52% 6.41%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 6.94% 8.00% 9.84% 14.48%
Cost of Revenue to Revenue
32.75% 33.26% 35.18% 34.39% 33.79% 34.10% 32.50% 31.34% 32.31% 33.25% 33.59%
SG&A Expenses to Revenue
9.75% 11.48% 9.69% 10.61% 10.68% 10.97% 11.73% 11.30% 10.61% 10.12% 9.81%
R&D to Revenue
13.86% 13.94% 13.60% 12.73% 12.31% 13.24% 14.12% 14.03% 13.57% 13.18% 12.24%
Operating Expenses to Revenue
49.33% 53.53% 53.55% 51.93% 51.05% 51.21% 53.76% 53.29% 49.38% 46.79% 44.49%
Earnings before Interest and Taxes (EBIT)
171 144 130 187 234 237 241 345 458 605 704
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
232 225 300 352 417 432 451 535 632 802 906
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.37 2.70 3.15 3.27 4.25 6.90 6.78 4.01 3.80 2.97 1.84
Price to Tangible Book Value (P/TBV)
4.82 0.00 0.00 46.37 20.49 25.47 20.74 10.04 10.46 7.08 8.43
Price to Revenue (P/Rev)
3.62 4.02 4.14 4.56 6.09 10.74 9.96 5.60 5.34 3.90 2.43
Price to Earnings (P/E)
12.96 34.93 38.48 41.38 51.55 90.11 96.08 45.90 37.53 24.13 11.68
Dividend Yield
1.13% 0.93% 0.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
7.71% 2.86% 2.60% 2.42% 1.94% 1.11% 1.04% 2.18% 2.66% 4.14% 8.56%
Enterprise Value to Invested Capital (EV/IC)
4.26 2.52 3.25 3.63 5.21 9.38 8.29 5.27 4.58 3.90 1.95
Enterprise Value to Revenue (EV/Rev)
2.73 4.20 4.08 4.37 5.76 10.28 9.66 5.19 5.03 3.48 2.29
Enterprise Value to EBITDA (EV/EBITDA)
10.88 18.94 18.11 17.95 21.76 39.21 41.14 21.15 18.93 11.88 7.43
Enterprise Value to EBIT (EV/EBIT)
14.74 29.50 41.92 33.84 38.70 71.40 77.12 32.76 26.15 15.75 9.56
Enterprise Value to NOPAT (EV/NOPAT)
18.55 37.30 32.78 37.46 47.86 84.52 84.92 43.83 37.20 23.85 11.99
Enterprise Value to Operating Cash Flow (EV/OCF)
10.01 18.68 13.77 15.93 24.23 35.26 40.18 23.58 21.32 11.44 9.40
Enterprise Value to Free Cash Flow (EV/FCFF)
11.00 0.00 29.51 63.82 47.59 125.23 0.00 32.51 0.00 16.65 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.31 0.26 0.23 0.21 0.26 0.29 0.22 0.20 0.13 0.00
Long-Term Debt to Equity
0.00 0.29 0.26 0.23 0.09 0.16 0.15 0.15 0.14 0.00 0.00
Financial Leverage
-0.51 -0.22 0.03 -0.09 -0.19 -0.27 -0.25 -0.26 -0.26 -0.27 -0.21
Leverage Ratio
1.32 1.53 1.68 1.61 1.60 1.62 1.65 1.62 1.56 1.50 1.39
Compound Leverage Factor
1.32 1.53 1.68 1.61 1.60 1.62 1.65 1.62 1.56 1.50 1.39
Debt to Total Capital
0.00% 23.54% 20.37% 18.44% 17.08% 20.83% 22.53% 17.87% 16.57% 11.29% 0.00%
Short-Term Debt to Total Capital
0.00% 1.07% 0.00% 0.00% 9.24% 7.95% 10.81% 5.63% 5.20% 11.29% 0.00%
Long-Term Debt to Total Capital
0.00% 22.46% 20.37% 18.44% 7.84% 12.89% 11.72% 12.24% 11.37% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.75% 0.35% 0.36% 0.33% 0.33% 0.00%
Common Equity to Total Capital
100.00% 76.46% 79.63% 81.56% 82.92% 78.41% 77.12% 81.77% 83.10% 88.37% 100.00%
Debt to EBITDA
0.00 2.07 1.49 1.30 1.12 1.58 1.83 1.24 1.05 0.57 0.00
Net Debt to EBITDA
0.00 0.80 -0.26 -0.78 -1.24 -1.81 -1.33 -1.70 -1.17 -1.45 0.00
Long-Term Debt to EBITDA
0.00 1.97 1.49 1.30 0.51 0.98 0.95 0.85 0.72 0.00 0.00
Debt to NOPAT
0.00 4.07 2.70 2.70 2.45 3.40 3.78 2.58 2.07 1.15 0.00
Net Debt to NOPAT
0.00 1.57 -0.47 -1.63 -2.73 -3.91 -2.74 -3.51 -2.31 -2.91 0.00
Long-Term Debt to NOPAT
0.00 3.89 2.70 2.70 1.13 2.10 1.96 1.76 1.42 0.00 0.00
Altman Z-Score
6.10 3.15 4.13 4.52 5.37 7.77 7.46 5.63 5.98 5.63 5.55
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.51% 0.69% 0.44% 0.42% 0.39% 0.18%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.73 1.08 1.32 1.38 0.93 1.86 1.81 2.12 2.06 1.70 1.55
Quick Ratio
1.59 0.95 1.19 1.24 0.81 1.69 1.43 1.83 1.78 1.54 1.30
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
230 -983 184 99 191 135 -214 348 -143 572 -457
Operating Cash Flow to CapEx
1,403.69% 637.82% 581.88% 622.94% 603.75% 758.97% 687.11% 585.80% 666.95% 834.59% 764.34%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.45 0.49 0.48 0.46 0.42 0.43 0.46 0.48 0.53 0.57
Accounts Receivable Turnover
5.57 4.64 5.43 5.57 5.18 5.29 5.50 4.77 4.31 4.45 4.26
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
22.95 15.83 12.94 11.17 11.16 11.80 13.56 14.31 14.25 15.21 15.72
Accounts Payable Turnover
1.39 1.26 1.46 1.34 1.29 1.29 1.28 1.24 1.31 1.40 1.55
Days Sales Outstanding (DSO)
65.56 78.63 67.26 65.53 70.45 68.96 66.37 76.48 84.72 82.01 85.63
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
262.39 290.08 249.46 272.68 283.34 283.31 284.65 294.47 278.95 260.53 234.97
Cash Conversion Cycle (CCC)
-196.83 -211.45 -182.20 -207.15 -212.89 -214.35 -218.28 -217.99 -194.24 -178.52 -149.35
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
593 1,690 1,672 1,742 1,741 1,806 2,238 2,149 2,613 2,440 3,459
Invested Capital Turnover
1.45 0.89 0.79 0.85 0.90 0.93 0.95 0.99 1.00 1.08 1.00
Increase / (Decrease) in Invested Capital
-93 1,098 -18 70 -1.09 65 433 -90 464 -173 1,019
Enterprise Value (EV)
2,527 4,263 5,436 6,318 9,067 16,934 18,555 11,313 11,968 9,528 6,732
Market Capitalization
3,355 4,084 5,513 6,593 9,584 17,692 19,142 12,207 12,696 10,678 7,150
Book Value per Share
$23.88 $25.39 $29.17 $33.10 $36.54 $41.09 $44.81 $47.92 $52.50 $57.10 $61.29
Tangible Book Value per Share
$11.74 ($6.59) ($2.00) $2.33 $7.57 $11.13 $14.64 $19.15 $19.07 $24.00 $13.41
Total Capital
1,415 1,977 2,197 2,473 2,722 3,270 3,663 3,720 4,021 4,062 3,877
Total Debt
0.00 465 448 456 465 681 825 665 666 459 0.00
Total Long-Term Debt
0.00 444 448 456 213 421 429 455 457 0.00 0.00
Net Debt
-828 179 -77 -275 -517 -783 -600 -907 -742 -1,163 -417
Capital Expenditures (CapEx)
18 36 68 64 62 63 67 82 84 100 94
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-149 -130 -223 -249 -253 -306 -0.51 -86 -6.05 -133 74
Debt-free Net Working Capital (DFNWC)
276 58 170 236 186 1,158 1,424 1,485 1,402 1,489 492
Net Working Capital (NWC)
276 36 170 236 -65 898 1,028 1,276 1,193 1,030 492
Net Nonoperating Expense (NNE)
-123 -2.63 23 9.30 3.53 4.02 19 -7.82 -17 -43 -51
Net Nonoperating Obligations (NNO)
-822 179 -77 -275 -517 -783 -600 -907 -742 -1,163 -417
Total Depreciation and Amortization (D&A)
61 81 170 165 182 195 210 189 174 197 202
Debt-free, Cash-free Net Working Capital to Revenue
-16.06% -12.77% -16.71% -17.27% -16.06% -18.58% -0.03% -3.96% -0.25% -4.85% 2.52%
Debt-free Net Working Capital to Revenue
29.81% 5.67% 12.74% 16.36% 11.84% 70.25% 74.13% 68.09% 58.96% 54.44% 16.69%
Net Working Capital to Revenue
29.81% 3.59% 12.74% 16.36% -4.15% 54.48% 53.52% 58.49% 50.16% 37.67% 16.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.35 $1.96 $2.37 $2.60 $2.99 $3.13 $3.15 $4.17 $5.32 $6.97 $9.82
Adjusted Weighted Average Basic Shares Outstanding
59.55M 59.67M 60.44M 61.39M 62.12M 62.71M 63.19M 63.79M 63.59M 63.48M 62.33M
Adjusted Diluted Earnings per Share
$4.22 $1.92 $2.31 $2.52 $2.88 $2.98 $2.98 $4.00 $5.11 $6.76 $9.67
Adjusted Weighted Average Diluted Shares Outstanding
61.28M 61.04M 62.12M 63.31M 64.66M 65.96M 66.90M 66.47M 66.27M 65.51M 63.32M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
59.53M 59.99M 60.93M 61.77M 62.40M 63.05M 63.48M 63.63M 62.87M 63.25M 60.43M
Normalized Net Operating Profit after Tax (NOPAT)
136 114 105 169 189 200 219 258 322 400 561
Normalized NOPAT Margin
14.70% 11.25% 7.89% 11.67% 12.04% 12.16% 11.37% 11.83% 13.53% 14.61% 19.06%
Pre Tax Income Margin
18.49% 14.23% 9.73% 12.93% 14.88% 14.39% 12.52% 15.83% 19.25% 22.11% 23.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
14.77% 32.67% 6.73% 0.00% 0.00% 0.00% 7.91% 0.14% 0.52% 0.69% 5.96%
Augmented Payout Ratio
41.19% 69.99% 23.77% 16.32% 25.43% 24.59% 44.64% 54.64% 85.79% 84.10% 85.83%

Quarterly Metrics And Ratios for NICE

No quarterly metrics and ratios for NICE are available.



Financials Breakdown Chart

Frequently Asked Questions About NICE's Financials

When does NICE's fiscal year end?

According to the most recent income statement we have on file, NICE's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has NICE's net income changed over the last 10 years?

NICE's net income appears to be on an upward trend, with a most recent value of $612.10 million in 2025, rising from $258.83 million in 2015. The previous period was $442.59 million in 2024.

What is NICE's operating income?
NICE's total operating income in 2025 was $645.76 million, based on the following breakdown:
  • Total Gross Profit: $1.96 billion
  • Total Operating Expenses: $1.31 billion
How has NICE's revenue changed over the last 10 years?

Over the last 10 years, NICE's total revenue changed from $926.87 million in 2015 to $2.95 billion in 2025, a change of 217.8%.

How much debt does NICE have?

NICE's total liabilities were at $1.23 billion at the end of 2025, a 27.4% decrease from 2024, and a 183.0% increase since 2015.

How much cash does NICE have?

In the past 10 years, NICE's cash and equivalents has ranged from $157.03 million in 2016 to $529.60 million in 2022, and is currently $379.39 million as of their latest financial filing in 2025.

How has NICE's book value per share changed over the last 10 years?

Over the last 10 years, NICE's book value per share changed from 23.88 in 2015 to 61.29 in 2025, a change of 156.6%.



Financial statements for OTCMKTS:NCSYF last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners